{"schema_version":"secwatch.filing_event.v1","accession":"0001654954-24-007083","form_type":"8-K","ticker":"EDSA","cik":"0001540159","company_name":"Edesa Biotech, Inc.","filed_at":"2024-05-30T23:59:59+00:00","discovered_at":"2026-05-14T18:03:18.903051+00:00","generated_at":"2026-06-01T07:23:18.935747+00:00","sec_items":["5.02","5.07","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"confidence":"high","headline":"Edesa Biotech shareholders approve 67,000-share increase to equity plan, re-elect all directors","bullets":["All seven director nominees elected with ~818-819 thousand votes for each; 654k broker non-votes.","Advisory vote on executive compensation approved: 677,967 for, 122,761 against, 62,400 abstain.","Plan amendment increasing shares by 67,000 approved: 660,015 for, 151,395 against, 51,718 abstain.","Approximately 47% of outstanding shares (1,517,529) represented at the meeting.","MNP LLP appointed as auditors for FY ending Sept 30, 2024 with 1,463,707 votes for."],"urls":{"canonical":"https://secwatch.observer/filing/0001654954-24-007083","json":"https://secwatch.observer/filing/0001654954-24-007083.json","markdown":"https://secwatch.observer/filing/0001654954-24-007083.md","text":"https://secwatch.observer/filing/0001654954-24-007083.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1540159/000165495424007083/0001654954-24-007083-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1540159/000165495424007083/edsa_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-01T07:23:18.935747+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}